Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the switch from tacrolimus to cyclosporine
microemulsion benefits post-transplant diabetes management (in terms of glycogenic control
and insulin dosage) in stable liver transplant recipients.